The DOI matches its Crossref record, with a small difference in title or year; 435 of the 435 references it cites were found in a registry or an index.
ESC/EAS Guidelines for the management of dyslipidaemias
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They also have significant non-lipid-lowering properties, including anti-inflammatory, antithrombotic, antioxidant or antiapoptotic activities (3,6).”
From The Role of Nutraceuticals in Statin Intolerant Patients (2018) · cites this paper as [6]
In the citing paper
“Statin therapy can reduce plasma cholesterol (3,5) and high-sensitivity C-reactive protein levels, and this is directly associated with a significant improvement in CV risk (1,2,6,149,150).”
From The Role of Nutraceuticals in Statin Intolerant Patients (2018) · cites this paper as [6]
Citations
Cites
Items 401–435 of 435
Holme, I., Cater, N. B., Færgeman, O., Kastelein, J. J. P., OLSSON, A. G., Tikkanen, M. J., Larsen, M. L., Lindahl, C., Pedersen, T. R., & Decrea, O. B. O. T. I. (2008) · Annals of Medicine · doi:10.1080/07853890801964955 · Cited by 53
Lea, L. J., & Hepburn, P. A. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.01.017 · Cited by 52
Cholesterol and cardiovascular disease
Tyroler, H. A. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90851-8 · Cited by 52
Statin adherence and mortality in patients enrolled in a secondary prevention program.
McGinnis, B., Olson, K. L., Delate, T., & Stolcpart, R. S. (2009) · PubMed · Cited by 49
Statins and renovascular disease in the elderly: a population-based cohort study
Hackam, D. G., Wu, F., Li, P., Austin, P. C., Tobe, S. W., Mamdani, M. M., & Garg, A. X. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq452 · Cited by 49
Myocardial infarction and third generation oral contraceptives: aggregation of recent studies
Spitzer, W. O. (2002) · Human Reproduction · doi:10.1093/humrep/17.9.2307 · Cited by 49
Zhao, X.-Q., Krasuski, R. A., Baer, J., Whitney, E. J., Neradilek, B., Chait, A., Marcovina, S., Albers, J. J., & Brown, B. G. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.07.035 · Cited by 48
Mistry, H., Morris, S., Dyer, M., Kotseva, K., Wood, D., & Buxton, M. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001029 · Cited by 48
Self-citationReiner, ?., Tedeschi-Reiner, E., & Romi??, ?. (2005) · Clinical Drug Investigation · doi:10.2165/00044011-200525110-00003 · Cited by 47
Self-citationWilhelmsen, L., Svärdsudd, K., Eriksson, H., Rosengren, A., Hansson, P.-O., Welin, C., Odén, A., & Welin, L. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02331.x · Cited by 47
Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis
Rabkin, S. W. (1984) · Atherosclerosis · doi:10.1016/0021-9150(84)90193-x · Cited by 43
Fish oil and the management of hypertriglyceridemia
Mattar, M., & Obeid, O. (2009) · Nutrition and Health · doi:10.1177/026010600902000105 · Cited by 43
Ojala, K., Repo-Tiihonen, E., Tiihonen, J., & Niskanen, L. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107077815 · Cited by 43
Whittall, R. A., Scartezini, M., Li, K., Hubbart, C., Reiner, Z., Abraha, A., Neil, H. A. W., Dedoussis, G., & Humphries, S. E. (2010) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009076 · Cited by 43
Statins for primary prevention of venous thromboembolism
Li, L., Zhang, P., Tian, J. H., & Yang, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008203.pub3 · Cited by 42
van Gils, P. F., Over, E. A. B., Reenen, H. H. H.-V., de Wit, G. A., van den Berg, M., Schuit, A. J., & Engelfriet, P. M. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000363 · Cited by 41
Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use
Holoshitz, N., Alsheikh-Ali, A. A., & Karas, R. H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.07.057 · Cited by 40
Perspectives on low-density-lipoprotein cholesterol goal achievement
Catapano, A. L. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802631438 · Cited by 40
Self-citationPlasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study
Herrmann, M., Whiting, M. J., Veillard, A.-S., Ehnholm, C., SULLIVAN, D. R., KEECH, A. C., & for the FIELD study investigators (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0078 · Cited by 38
Corrao, G., Scotti, L., Zambon, A., Baio, G., Nicotra, F., Conti, V., Capri, S., Tragni, E., Merlino, L., Catapano, A. L., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.014 · Cited by 33
Self-citationAntonini-Canterin, F., Moura, L. M., Enache, R., Leiballi, E., Pavan, D., Piazza, R., Popescu, B. A., Ginghină, C., Nicolosi, G. L., & Rajamannan, N. M. (2010) · Circulation · doi:10.1161/circulationaha.109.891598 · Cited by 32
Plans-Rubió, P. (2010) · American Journal Cardiovascular Drugs · doi:10.2165/11539150-000000000-00000 · Cited by 31
The efficacy and tolerability of ezetimibe in cardiac transplant recipients taking cyclosporin
Shaw, S. M., Chaggar, P., Ritchie, J., Shah, M. K. H., Baynes, A. C., O’Neill, N., Fildes, J. E., Yonan, N., & Williams, S. G. (2009) · Transplantation · doi:10.1097/tp.0b013e318198d7d0 · Cited by 31
Peura, P., Martikainen, J., Soini, E., Hallinen, T., & Niskanen, L. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802144705 · Cited by 29
Rosengren, A. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr364 · Cited by 29
Low-density lipoprotein apheresis as a treatment option for hyperlipidemia
Mehta, P. K., Baer, J., Nell, C., & Sperling, L. S. (2009) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-009-0029-1 · Cited by 26
Wisløff, T., Selmer, R. M., Halvorsen, S., Fretheim, A., Norheim, O. F., & Kristiansen, I. S. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-26 · Cited by 26
Lowering LDL cholesterol in adults: a prospective, community-based practice initiative
Coodley, G. O., Jorgensen, M., Kirschenbaum, J., Sparks, C., Zeigler, L., & Albertson, B. D. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.02.031 · Cited by 23
Low glycaemic index diets for coronary heart disease
Kelly, S. A., Summerbell, C., Ashton, V. J., & Frost, G. S. (2003) · doi:10.1002/14651858.cd004467 · Cited by 22
Vidt, D. G. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0046-9 · Cited by 18
Lipids, nutrition, and coronary heart disease.
Grundy, S. M., Fuster, V., Ross, R., & Topol, E. J. (1996) · Cited by 17
Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus
Levy, P. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0087 · Cited by 15
Neyt, M., Laet, C. D., Brabandt, H. V., Franco, O., & Ramaekers, D. (2009) · Acta Cardiologica · doi:10.2143/ac.64.1.2034354 · Cited by 15
Statins for Cardiovascular Prevention According to Different Strategies: A Cost Analysis
Ito, M. K., Nanchen, D., Rodondi, N., Paccaud, F., Waeber, G., Vollenweider, P., & Marques-Vidal, P. (2011) · American Journal Cardiovascular Drugs · doi:10.2165/11586760-000000000-00000 · Cited by 11
HMG CoA reductase inhibitors (statins) for kidney transplant recipients
Navaneethan, S. D., Perkovic, V., Nigwekar, S. U., Johnson, D. W., Craig, J. C., & Strippoli, G. F. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005019.pub2 · Cited by 11
Flagged first, then by citations
Research works printed but not linked: 3
- De Backer, 2003, Eur J Cardiovasc Prev Rehabil, 10, S1
- Poulter, 1999, The impact of micronized fenofibrate on lipid subfractions and on reaching HDL-target levels in 7,098 patients with dyslipidaemia, Br J Cardiol, 6, 682
- DeMott K, Nherera L, Shaw EJ, Minhas R, Humphries SE, Kathoria M, Ritchie G, Nunes V, Davies D, Lee P, McDowell I, Neil A, Qureshi N, Rowlands P, Seed M, Stracey H, Thorogood M, Watson M. Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2008.
Cited by
Sorted by citations
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
Salminen, P., Helmiö, M., Ovaska, J., Juuti, A., Leivonen, M., Peromaa-Haavisto, P., Hurme, S., Soinio, M., Nuutila, P., & Victorzon, M. (2018) · JAMA · doi:10.1001/jama.2017.20313 · Cited by 946
Martin, S. S., Blaha, M. J., Elshazly, M. B., Toth, P. P., Kwiterovich, P. O., Blumenthal, R. S., & Jones, S. R. (2013) · JAMA · doi:10.1001/jama.2013.280532 · Cited by 883
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Benn, M., Watts, G. F., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1563 · Cited by 632
Metadata
- Authors
- Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Perrone Filardi, P., Riccardi, G., Storey, R. F., & Wood, D.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Catapano, Alberico L.
- Reiner, Željko
- ORCID
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 217
- Issue
- 1
- Pages
- 3-46
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W3031812472
- Cited by
- 706
- References
- 435
- Citations by year
- 2025: 8 · 2024: 6 · 2023: 16 · 2022: 11 · 2021: 22 · 2020: 27 · 2019: 33 · 2018: 53 · 2017: 70 · 2016: 104 · 2015: 97 · 2014: 104 · 2013: 93 · 2012: 53
- FWCI
- 84.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- dyslipidemia, dyslipidemia management, lipid-lowering therapy, cardiovascular risk, hypercholesterolemia, hypertriglyceridemia, cardiovascular disease prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
